The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism.

The study found that individuals who have at least one inactive copy of the GPR75 gene have lower body mass ... its large-molecule GLP-1/glucagon dual agonist cotadutide which has reached mid ...

According to a new study published in the journal Biomedicine & Pharmacotherapy, CBD oil may help counteract the negative effects of a high-calorie diet by influencing insulin and glucagon regulation ...

A team of undergraduate researchers has developed an innovative way to produce essential medications more affordably and ...

The first rare disease gene therapies on the market were based ... such as GLP-1/gastric inhibitory peptide (GIP), GLP-1/glucagon, and GLP-1/amylin. IQVIA also found there were 50 other mechanisms ...

Feb. 26, 2025 — A new study details the discovery of rare gene variants that increase the ... have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists ...

Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.

As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead liver-targeting gene therapy into human trials. The series C was led by Arch ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

Gene Hackman and his wife Betsy had established each other as the personal representatives of their estates before they were both found dead on Feb. 26 Gene Hackman and his wife Betsy's wills have ...